Search
TG Therapeutics Inc
TGTXAdd to Watchlist
58.110USD
+0.950+1.66%
Close 09-22 16:00（ET）
8.90BMarket Cap
18.15P/E TTM
Pre-market 04:36 (ET)58.300USD+0.190+0.33%
Pre-market 04:36 (ET)TG Therapeutics Inc (TGTX) Stock Price Target & Forecast
Analyst Rating
Based on 8 analysts giving stock ratings to TG Therapeutics Inc in the past month.
Buy
1 Strong Buy
6 Buy
0 Hold
1 Sell
0 Strong Sell
Target Price
69.333USD+21.92%
TGTX Analyst Recommendation Trends
In the current month, TGTX has received 6 Buy Ratings, 0 Hold Ratings, and 1 Sell Ratings. TGTX average Analyst price target in the last month is 69.333.
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2026-02
1
1
1
1
1
1
1
1
6
6
6
6
6
6
6
6
0
0
1
1
1
1
1
1
0
0
0
0
0
0
0
0
1
1
1
1
1
1
1
1
8
8
9
9
9
9
9
9
TGTX Analyst Rating for Peer Comparison
Updated: Sep 22, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Biogen Inc
BIIB
7
17
12
1
0
37
Amgen Inc
AMGN
4
9
21
2
1
37
Eli Lilly and Co
LLY
10
17
6
1
0
34
AbbVie Inc
ABBV
8
19
6
0
0
33
Alnylam Pharmaceuticals Inc
ALNY
7
17
8
0
0
32
Merck & Co Inc
MRK
8
14
10
0
0
32
Pfizer Inc
PFE
5
6
19
1
1
32
Gilead Sciences Inc
GILD
7
18
6
0
0
31
Vertex Pharmaceuticals Inc
VRTX
9
16
5
0
1
31
Regeneron Pharmaceuticals Inc
REGN
6
14
10
0
0
30
Financial Forecasting
Based on analysts' estimates, TGTX EPS is projected to reach 0.362 in FY2026Q3, following reported EPS of 0.055 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
0.35
0.29
0.34
0.36
0.44
Actual
0.17
0.14
0.05
--
--
Surprise
-52.63%
-53.52%
-83.74%
--
--
FAQs
What is TG Therapeutics Inc's expected revenue for the next quarter?
TG Therapeutics Inc's expected revenue is 247.06M.
What is TG Therapeutics Inc's price target?
Analysts forecast that TG Therapeutics Inc's price target is USD 69.33, with the highest forecast at USD 86.00 and the lowest forecast at USD 21.00.
How have TG Therapeutics IncTGTX's recent earnings per share performed?
The market expectation was USD 0.05, while TG Therapeutics IncTGTX's earnings per share (EPS) for the previous quarter was USD 0.14. EPS for the next quarter is expected at USD 0.36.
What is the analyst rating for TG Therapeutics Inc?
Based on the ratings of TG Therapeutics Inc's stock from 8 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.